1,2,3-Triazole incorporated coumarin derivatives as potential antifungal and antioxidant agents

Chinese Chemical Letters

Volumn 27, Issue 2, 2016, Pages 295-301

  Shaikh, Mubarak H ^a   Subhedar, Dnyaneshwar D ^a   Khan, Firoz A Kalam ^b   Sangshetti, Jaiprakash N ^b   Shingate, Bapurao B ^a  

^a DR BABASAHEB AMBEDKAR MARATHWADA UNIVERSITY   (India)

^b Y B CHAVAN COLLEGE OF PHARMACY   (India)

Author keywords

1,2,3 Triazole; ADME prediction; Antifungal; Antioxidant; Docking study

Indexed keywords

EID: 84979301046     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2015.11.003     Document Type: Article

References (48)

1. Sheehan, D.J., Hitchcock, C.A., Sibley, C.M., Current and emerging azole antifungal agents. Clin. Microbiol. Rev. 12 (1999), 40–79.
2. Cha, R., Sobel, J.D., Fluconazole for the treatment of candidiasis: 15 years experience. Expert Rev. Anti-Infect. Ther. 2 (2004), 357–366.
3. Georgopapadakou, N.H., Walsh, T.J., Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemoth. 40 (1996), 279–291.
4. Pfaller, M.A., Messer, S.A., Hollis, R.J., Jones, R.N., In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans. Antimicrob. Agents Chemoth. 45 (2001), 2862–2864.
5. Jeu, L., Piacenti, F.J., Lyakhovetskiy, A.G., Fung, H.B., Voriconazole. Clin. Ther. 25 (2003), 1321–1381.
6. Lepesheva, G.I., Zaitseva, N.G., Nes, W.D., et al. CYP51 from trypanosomacruzi: a phyla-specific residue in the B′ helix defines substrate preferences of sterol 14α-demethylase. J. Biol. Chem. 281 (2006), 3577–3585.
7. Ilango, K., Biju, C.R., In silico docking investigation, synthesis and cytotoxic studies of coumarin substituted 1, 3, 4-oxadiazole derivatives. J. Pharm. Res. 5 (2012), 1514–1517.
8. Ronad, P.M., Noolvi, M.N., Sapkal, S., et al. Synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-benzopyran-2-one derivatives. Eur. J. Med. Chem. 45 (2010), 85–89.
9. Raghu, M., Nagaraj, A., Reddy, C.S., Synthesis and in vitro study of novel bis-[3-(2-arylmethylidenimino-1,3-thiazol-4-yl)-4-hydroxy-2H-chromen-2-one-6-yl]methane and bis-[3-(2-arylidenhydrazo-1,3-thiazol-4-yl)-4-hydroxy-2H-chromen-2-one-6-yl]methane as potential antimicrobial agents. J. Heterocyclic Chem. 46 (2009), 261–267.
10. Gouda, M.A., Berghot, M.A., Baz, E.A., et al. Synthesis, antitumor and antioxidant evaluation of some new thiazole and thiophene derivatives incorporated coumarin moiety. Med. Chem. Res. 21 (2012), 1062–1070.
11. Sun, J., Ding, W.X., Zhang, K.Y., Zou, Y., Efficient synthesis and biological evaluation of 4-arylcoumarin derivatives. Chin. Chem. Lett. 22 (2011), 667–670.
12. Gutteridge, J.M.C., Halliwell, B., Invited review free radicals in disease processes: a compilation of cause and consequence. Free Radical Res. Commun. 19 (1993), 141–158.
13. Patel, R.M., Patel, N.J., In vitro antioxidant activity of coumarin compounds by DPPH, super oxide and nitric oxide free radical scavenging methods. J. Adv. Pharm. Technol. Res. 1 (2011), 52–68.
14. Murakami, A., Gao, G.X., Omura, M., et al. 1,1-Dimethylallylcoumarins potently supress both lipopolysaccharide- and interferon-γ-induced nitric oxide generation in mouse macrophage RAW 264.7 cells. Bioorg. Med. Chem. Lett. 10 (2000), 59–62.
15. Lima-Neto, R.G., Cavalcante, N.N.M., Srivastava, R.M., et al. Synthesis of 1,2,3-triazole derivatives and in vitro antifungal evaluation on Candida strains. Molecules 17 (2012), 5882–5892.
16. Boechat, N., Ferreira, V.F., Ferreira, S.B., et al. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain. J. Med. Chem. 54 (2011), 5988–5999.
17. He, J.L., Xie, J.P., Advances in Mycobacterium siderophore-based drug discovery. Acta Pharm. Sin. B 1 (2011), 8–13.
18. Agalave, S.G., Maujan, S.R., Pore, V.S., Click chemistry: 1,2,3-triazoles as pharmacophores. Chem. Asian J. 6 (2011), 2696–2718.
19. Senger, M.R., Gomes, L.D.C.A., Ferreira, S.B., et al. Kinetics studies on the inhibition mechanism of pancreatic α-amylase by glycoconjugated 1H-1,2,3-triazoles: a new class of inhibitors with hypoglycemiant activity. Chem. Biol. Chem. 13 (2012), 1584–1593.
20. Zhao, X., Lu, B.W., Lu, J.R., et al. Design, synthesis and antimicrobial activities of 1,2,3-triazole derivatives. Chin. Chem. Lett. 23 (2012), 933–935.
21. Bochis, R.J., Chabala, J.C., Harris, E., et al. Benzylated 1,2,3-triazoles as anticoccidiostats. J. Med. Chem. 34 (1991), 2843–2852.
22. Kelley, J.L., Koble, C.S., Davis, R.G., et al. 1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: synthesis and anticonvulsant activity. J. Med. Chem. 38 (1995), 4131–4134.
23. Li, Q.H., Ding, Y., Huang, N.W., Synthesis and biological activities of dithiocarbamates containing 1,2,3-triazoles group. Chinese Chem. Lett. 25 (2014), 1469–1472.
24. Raj, R., Singh, P., Singh, P., et al. Azide-alkyne cycloadditionen route to 1H-1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: synthesis and antimalarial evaluation. Eur. J. Med. Chem. 62 (2013), 590–596.
25. Jordao, A.K., Afonso, P.P., Ferreira, V.F., et al. Antiviral evaluation of N-amino-1,2, 3-triazoles against cantagalo virus replication in cell culture. Eur. J. Med. Chem. 44 (2009), 3777–3783.
26. Wilkinson, B.L., Long, H., Sim, E., Fairbanks, A.J., Synthesis of Arabino glycosyltriazoles as potential inhibitors of mycobacterial cell wall biosynthesis. Bioorg. Med. Chem. Lett. 18 (2008), 6265–6267.
27. Kume, M., Kubota, T., Kimura, Y., et al. Orally active cephalosporins II. Synthesis and structure-activity relationships of new 7-β-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-cephalosporins with 1,2,3-triazole in C-3 side chain. J. Antibiot. 46 (1993), 177–192.
28. Shi, Y., Zhou, C.H., Synthesis and evaluation of a class of new coumarintriazole derivatives as potential antimicrobial agents. Bioorg. Med. Chem. Lett. 21 (2011), 956–960.
29. Kushwaha, K., Kaushik, N., Lata, Jain, S.C., Design and synthesis of novel 2H-chromen-2-one derivatives bearing 1,2,3-triazole moiety as lead antimicrobials. Bioorg. Med. Chem. Lett. 24 (2014), 1795–1801.
30. Kusanur, R.A., Kulkarni, M.V., New 1,3-dipolar cycloadducts of 3-azidoacetylcoumarins with DMAD and their antimicrobial activity. Indian J. Chem. B 44 (2005), 591–594.
31. Shaikh, M.H., Subhedar, D.D., Nawale, L., et al. 1,2,3-Triazole derivatives as antitubercular agents; Synthesis, biological evaluation and molecular docking study. Med. Chem. Commun. 6 (2015), 1104–1116.
32. Nikalje, A.P.G., Ghodke, M.S., Khan, F.A.K., Sangshetti, J.N., CAN catalyzed one-pot synthesis and docking study of some novel substituted imidazole coupled 1,2,4-triazole-5-carboxylic acids as antifungal agents. Chin. Chem. Lett. 26 (2015), 108–112.
33. Sangshetti, J.N., Khan, F.A.K., Chouthe, R.S., Damale, M.G., Shinde, D.B., Synthesis, docking and ADMET prediction of novel 5-((5-substituted-1H-1,2,4-triazol-3-yl) methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine as antifungal agents. Chin. Chem. Lett. 25 (2014), 1033–1038.
34. Shingate, B.B., Hazra, B.G., Salunke, D.B., Pore, V.S., Deshpande, M.V., Stereoselective synthesis and antimicrobial activity of steroidal C-20 tertiary alcohols with thiazole/pyridine side chain. Eur. J. Med. Chem. 46 (2011), 3681–3689.
35. Kategaonkar, A.H., Shinde, P.V., Kategaonkar, A.H., et al. Synthesis and biological evaluation of new 2-chloro-3-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)quinoline derivatives via click chemistry approach. Eur. J. Med. Chem. 45 (2010), 3142–3146.
36. th ed., 1992, ELBS, London.
37. Burits, M., Bucar, F., Antioxidant activity of nigella sativa essential oil. Phytother. Res. 14 (2000), 323–328.
38. Halgren, T.A., Merck molecular force field. I. Basis form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 17 (1996), 490–519.
39. Hooft, R.W.W., Vriend, G., Sander, C., Abola, E.E., Errors in protein structures. Nature, 381, 1996, 272.
40. VLife Molecular Design Suite 4.3, VLife Sciences Technologies Pvt. Ltd., www.Vlifesciences.com.
41. Lipinski, C.A., Lombardo, L., Dominy, B.W., Feeney, P.J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (2001), 3–26.
42. Molinspiration Chemoinformatics Brastislava, Slovak Republic, Available from: http://www.molinspiration.com/cgi-bin/properties 2014.
43. Zhao, Y.H., Abraham, M.H., Le, J., et al. Rate-limited steps of human oral absorption and QSAR studies. Pharm. Res. 19 (2002), 1446–1457.
44. Drug-likeness and molecular property prediction, available from: http://www.molsoft.com/mprop/.
45. Alvarez, S.G., Alvarez, M.T., A practical procedure for the synthesis of alkyl azides at ambient temperature in dimethyl sulfoxide in high purity and yield. Synthesis 4 (1997), 413–414.
46. Mendelson, W.L., Hayden, S., Preparation of 2,4-dihydroxybenzaldehyde by the Vilsmeier-Haack reaction. Synthetic Commun. 26 (1996), 603–610.
47. Srinivasan, K.K., Neelima, Y., Alex, J., et al. Synthesis of novel furobenzopyrone derivatives and evaluation of their antimicrobial and antiinflammatory activity. Indian J. Pharm. Sci. 69 (2007), 326–331.
48. Ertl, P., Rohde, B., Selzer, P., Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 43 (2000), 3714–3717.